I saw 94-year-old Mrs. M in an outreach clinic. Mrs. M was being treated for hypertension. She was enjoying a healthy life until 6 months previous when she was diagnosed with hypertension on a routine physical examination. She was told that her blood pressure was mildly elevated. Anti-hypertensive therapy was initiated with a β-adrenergic receptor blocking agent. On each of the subsequent visits, a new anti-hypertensive agent was added to her drug regimen, and eventually, to achieve the ideal control of blood pressure, her anti-hypertensive drug regimen consisted of a maximum dose of a β-adrenergic receptor blocking agent, a high dose of a calcium-channel blocker, and a high dose of an α-adrenergic receptor blocking agent, along with a high dose of a diuretic agent.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Emergency Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Accepted: October 29, 2001
Received: July 2, 2001
© 2002 Elsevier Science Inc. Published by Elsevier Inc. All rights reserved.